OraSure Technologies, Inc. (OSUR) vs Rocket Pharmaceuticals, Inc. (RCKT)
A side-by-side comparison of OraSure Technologies, Inc. and Rocket Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
OSUR
OraSure Technologies, Inc.
$3.87HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT
RCKT
Rocket Pharmaceuticals, Inc.
$2.51HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT
Total return — OSUR vs RCKT
growth of $100 · dividends reinvested · last 10yOSUR -48.7% (-6.5%/yr)RCKT -92.8% (-23.1%/yr)OSUR compounded faster over this window
Log scale — wide-divergence pair
OSUR RCKT
OSUR vs RCKT: by the numbers
- •RCKT is the larger company ($274M vs $266M market cap).
- •Both run net losses; RCKT's is the smaller (0.00% vs -43.70% net margin).
Metrics side by side
Valuation
| Metric | OSUR | RCKT |
|---|---|---|
| P/S ratio | 2.37 | N/A |
| P/B ratio | 0.84 | 0.74 |
Profitability
| Metric | OSUR | RCKT |
|---|---|---|
| Gross margin | 41.38% | 0.00% |
| Operating margin | -59.23% | 0.00% |
| Net margin | -43.70% | 0.00% |
| ROE | -15.46% | -4.68% |
| ROIC | -15.00% | -48.92% |
Growth (annualized)
| Metric | OSUR | RCKT |
|---|---|---|
| Revenue CAGR (5Y) | -13.12% | N/A |
| Total return CAGR (5Y) | -17.56% | -38.33% |
Frequently asked
- How have OSUR and RCKT total returns compared?
- Over the past 10 years, OSUR delivered -6.51% and RCKT delivered -23.48% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.